Science News
from research organizations

Examining cost-effectiveness of initial diagnostic exams for microscopic hematuria

Date:
April 17, 2017
Source:
The JAMA Network Journals
Summary:
Routine urinalysis for screening of genitourinary cancer isn't recommended by any major health group but patients who undergo urinalysis for a variety of other reasons are often found to have microscopic hematuria, which prompts further evaluation. A new article explores the cost-effectiveness of four initial diagnostic protocols for these patients.
Share:
FULL STORY

Detecting red blood cells in the urine of asymptomatic patients who don't see blood when they urinate (asymptomatic microscopic hematuria) is common but it can signal cancer in the genitourinary system.

Routine urinalysis for screening of genitourinary cancer isn't recommended by any major health group but patients who undergo urinalysis for a variety of other reasons are often found to have microscopic hematuria, which prompts further evaluation. A new article published by JAMA Internal Medicine explores the cost-effectiveness of four initial diagnostic protocols for these patients.

Joshua A. Halpern, M.D., M.S., of Weill Cornell Medicine, New York, and his coauthors analyzed the cost-effectiveness of: computed tomography (CT) alone, cystoscopy (using a scope to examine the urinary tract) alone, CT and cystoscopy combined, and renal (kidney) ultrasound and cystoscopy combined.

The combination of cystoscopy and renal ultrasound was the most cost-effective with an incremental cost of $53,810 per cancer detected, according to the results.

"The use of ultrasound in lieu of CT as the first-line diagnostic strategy will reduce the cost, morbidity and national expenditures associated with evaluation of AMH [asymptomatic microscopic hematuria]. Clinicians and policy makers should consider changing future guidelines in accordance with this finding," the article concludes.


Story Source:

Materials provided by The JAMA Network Journals. Note: Content may be edited for style and length.


Journal Reference:

  1. Hassan Ghomrawi, PhD, MPH et al. Cost-effectiveness of Common Diagnostic Approaches for Evaluation of Asymptomatic Microscopic Hematuria. JAMA Intern Med, April 2017 DOI: 10.1001/jamainternmed.2017.0739

Cite This Page:

The JAMA Network Journals. "Examining cost-effectiveness of initial diagnostic exams for microscopic hematuria." ScienceDaily. ScienceDaily, 17 April 2017. <www.sciencedaily.com/releases/2017/04/170417114813.htm>.
The JAMA Network Journals. (2017, April 17). Examining cost-effectiveness of initial diagnostic exams for microscopic hematuria. ScienceDaily. Retrieved May 25, 2017 from www.sciencedaily.com/releases/2017/04/170417114813.htm
The JAMA Network Journals. "Examining cost-effectiveness of initial diagnostic exams for microscopic hematuria." ScienceDaily. www.sciencedaily.com/releases/2017/04/170417114813.htm (accessed May 25, 2017).

RELATED STORIES